Evidence map›Paper›PMID 15472328›Full record

ArticleJournal of clinical microbiology2004

Accuracy of phenotypic and genotypic testing for identification of Streptococcus pneumoniae and description of Streptococcus pseudopneumoniae sp. nov.

Judy C Arbique, Claire Poyart, Patrick Trieu-Cuot, Gilles Quesne, Maria da Glória S Carvalho, Arnold G Steigerwalt, Roger E Morey, Delois Jackson, Ross J Davidson, Richard R Facklam

Abstract readEvaluation Study
In one paragraph

Article in Journal of clinical microbiology, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 128 papers.

0numbers the graph read from it
0cells of the map it votes in
128citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

128 citing papers in PubMed.

  1. Early-life carriage and antibiotic resistance ofFrontiers in microbiology · 2026
    Article
  2. Review
  3. Re-evaluation of boundaries ofInternational journal of systematic and evolutionary microbiology · 2025
    Article
  4. A novel LAMP-based assay for the identification ofJournal of clinical microbiology · 2024
    Article
  5. Article
  6. Evaluation of ImmulexHeliyon · 2023
    Article
  7. Antibiotics (Basel, Switzerland) · 2023
    Review
  8. Article
  9. Article
  10. Review
  11. Iranian journal of microbiology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Antibiotics (Basel, Switzerland) · 2021
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

68 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Judy C ArbiqueDepartment of Microbiology, Division of Pathology and Laboratory Medicine, Queen Elizabeth II Health Sciences Centre, Halifax, Nova Scotia, Canada. j.arbique@ns.sympatico.ca
Claire Poyart
Patrick Trieu-Cuot
Gilles Quesne
Maria da Glória S Carvalho
Arnold G Steigerwalt
Roger E Morey
Delois Jackson
Ross J Davidson
Richard R Facklam

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We have identified an unusual group of viridans group streptococci that resemble Streptococcus pneumoniae. DNA-DNA homology studies suggested that a subset of these isolates represent a novel species that may be included in the S. oralis-S. mitis group of viridans group streptococci. We suggest that this novel species be termed Streptococcus pseudopneumoniae. A combination of phenotypic and genetic reactions allows its identification. S. pseudopneumoniae strains do not have pneumococcal capsules, are resistant to optochin (inhibition zones, less than 14 mm) when they are incubated under an atmosphere of increased CO2 but are susceptible to optochin (inhibition zones, >14 mm) when they are incubated in ambient atmospheres, are not soluble in bile, and are positive by the GenProbe AccuProbe Pneumococcus test. The bile solubility test is more specific than the optochin test for identification of S. pneumoniae. Genetic tests for pneumolysin (ply) and manganese-dependent superoxide dismutase (sodA) and identification tests with a commercial probe, AccuProbe Pneumococcus, do not discriminate between the new species and S. pneumoniae.

Indexed as

Bacterial Typing TechniquesBileCulture MediaDNA, RibosomalGenotypeHumansMolecular Sequence DataNucleic Acid HybridizationPhenotypePhylogenyQuinineRNA, Ribosomal, 16SSequence Analysis, DNASolubilitySpecies SpecificityStreptococcus pneumoniaeCulture MediaDNA, RibosomalethylhydrocupreineQuinineRNA, Ribosomal, 16S

Identifiers

PMID15472328
PMCPMC522306

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.